semaglutide and nafld Metabolic dysfunction-associated steatotic liver disease (MASLD) affects nearly one in three adults worldwide, yet many cases remain undiagnosed until advanced fibrosis or cirrhosis develops. So, which patients should clinicians actually be screening? Semaglutide reduced inflammation and oxidative

This post-surgical gut paralysis renders some patients unable to eat while saddling them with serious constipation, bloating, and discomfort and keeping them in hospital much longer than they otherwise would have been

It is essential to monitor for adverse events such as hypoglycemic episodes and blood pressure changes when using semaglutide, particularly in individuals with cardiovascular disease or risk factors related to heart attack and stroke

Resources OASIS 4 Trial Oral Semaglutide 25 mg in Adults with Overweight or Obesity (New England Journal of Medicine, 2025) New Drug Approved Wegovy (semaglutide) Tablets Novo Nordisk Official Press Release Wegovy Pill FDA Approval (December 2025) GoodRx Wegovy Pill vs

However, the subclinical form of the disease is much more prevalent under field conditions (Irmak et al., 2025)

Vomiting signals your gastrointestinal system cannot tolerate the medication during active illness

Many people using this medication do not have serious side effects